The guide provides considerations and strategies for clinicians and organizations implementing evidence-based practices. The approaches are designed to assist clinicians, behavioral health organizations, primary care providers, insurers, and policy makers in understanding, selecting, and implementing evidence-based interventions that support adults with concurrent substance use and/or concurrent substance use disorders.

The guide presents three evidence-based practices that engage and improve outcomes for individuals with concurrent substance use and concurrent substance use disorders:

• FDA-approved pharmacotherapy together with counseling to treat two substance combinations:

    1. alcohol and cocaine dependence and

    2. cocaine and opioid dependence

• Contingency management together with FDA-approved pharmacotherapy and counseling to treat two substance combinations:

    1. cocaine and opioid use and dependence and

    2. cocaine dependence and alcohol and opioid use

• Twelve-step facilitation therapy together with FDA-approved pharmacotherapy and counseling to treat two substance combinations:

    1. cocaine and opioid dependence and

    2. opioid and other substance dependence

Treating Concurrent Substance Abuse Among Adults